SCHEMBL6004354

SCHEMBL6004354

Cc1nc2cnccc2cc1O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.58
KDM4E B2RXH2 2/20 0.58
ALDH1A1 P00352 1/20 0.58
GAA P10253 1/20 0.58
STAT3 P40763 1/20 0.58
DAO P14920 2/20 0.42
PDGFRB P09619 3/20 0.39
PDGFRA P16234 3/20 0.39
EGFR P00533 2/20 0.39
LMNA P02545 1/20 0.37
PRNP P04156 1/20 0.37
HTT P42858 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
NOD2 Q9HC29 1/20 0.37
MAPKAPK2 P49137 1/20 0.36
CSNK1D P48730 1/20 0.35
CSNK1E P49674 1/20 0.35
CLK1 P49759 1/20 0.35
DYRK1A Q13627 1/20 0.35
MAP4K4 O95819 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3892453 0.85 KDM4E (0.58) HPGDKDM4EALDH1A1GAASTAT3
SCHEMBL13263596 0.80 CSNK1D (0.37) HPGDKDM4EALDH1A1GAASTAT3
SCHEMBL28149552 0.77 DAO (0.42) HPGDKDM4EALDH1A1GAASTAT3
SCHEMBL19070575 0.77 HASPIN (0.38) HPGDKDM4EALDH1A1GAASTAT3
SCHEMBL24253585 0.77 DAO (0.39) HPGDKDM4EALDH1A1GAASTAT3
SCHEMBL3788781 0.75 ALDH1A1 (0.61) HPGDKDM4EALDH1A1LMNAHTT
SCHEMBL22793012 0.74 RPS6KA3 (0.36) HTTCSNK1DCSNK1ECLK1DYRK1A
SCHEMBL1467531 0.74 ALDH1A1 (1.00) HPGDKDM4EALDH1A1GAASTAT3
SCHEMBL15119495 0.72 ALDH1A1 (0.62) HPGDKDM4EALDH1A1GAASTAT3
SCHEMBL2501659 0.72 TOP2A (0.45) KDM4EDAOPDGFRBPDGFRAEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220048890-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING SKYHAWK THERAPEUTICS, INC. 2022-02-17 US disclosed
WO-2020163248-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING SKYHAWK THERAPEUTICS, INC. (US) 2020-08-13 WO disclosed
EP-1724268-A1 COMPOUND HAVING TGF-BETA INHIBITORY ACTIVITY AND PHARMACEUTICAL COMPOSITION CONTAINING SAME KIRIN BEER KABUSHIKI KAISHA (JP) 2006-11-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220048890-A1 METHODS AND COMPOSITIONS FOR MODULATING SPLICING RBM17, SF3B1, SF3B5 HPGD 3316/4885KDM4E 2544/4885ALDH1A1 3964/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.